Real-world evidence: what population studies reveal Two large-scale observational studies have examined the relationship between GLP-1 receptor agonist use and autoimmune disease outcomes, and their findings partially conflict
The standard clinical protocol begins with a 0.25 mg starting dose and increases gradually over 16 weeks to a maintenance dose of 2.4 mg weekly
Investigative studies have revealed that an excess of iron ions plays a crucial role in inducing the conversion of M2 macrophages into M1 macrophages and suppressing myeloid suppressor cells (MDSCs) 6,7 , thus effectively alleviating the immunosuppressive TME and realizing the metal ions-mediated metallo-immunotherapy
Chen H, Hu J, Chen PR, et al
Branded versions of these medications, such as Mounjaro and Zepbound, have shown significant results in clinical trials for weight management
Ali Furman (16:32) For sure